Siemens Healthineers stock holds EUR 38.68 vs EUR 38.61, plus 0.18 percent
Published on 09/30/2026 at 10:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Siemens Healthineers stock was trading at EUR 38.68 at Lang & Schwarz on September 30, 2026, versus the EUR 38.61 prior close, up 0.18 percent. The latest market signal is a continuing share buyback, while JPMorgan's fresh view puts the spotlight on the company's Accela radiotherapy platform.
Buyback reaches 3.374 million shares
According to EQS News on September 28, 2026, Siemens Healthineers bought 160,000 shares between September 21 and September 27. The cumulative volume since June 1, 2026, reached 3,374,359 shares, with the purchases executed through Xetra.
The buyback gives the market a measurable capital-allocation reference. The latest tranche is 4.74 percent of the cumulative volume, calculated from 160,000 shares divided by 3,374,359 shares, so the program has continued in regular weekly steps rather than through one isolated purchase.
Accela lifts the analyst debate
According to Aktiencheck on September 29, 2026, JPMorgan kept Siemens Healthineers at Overweight with a EUR 57.40 price target. The bank highlighted Accela after its presentation in Boston and pointed to potential efficiency gains from faster radiotherapy workflows.
The target stands EUR 18.72 above the Lang & Schwarz price, or 48.40 percent higher. That comparison is a valuation reference, not a forecast from this article, and the market still has to translate the platform's operational benefits into reported earnings.
Recent reported figures provide that earnings benchmark. Investing.com lists Siemens Healthineers' Q3 fiscal 2026 revenue at EUR 5.76 billion and EPS at EUR 0.70, against an EPS forecast of EUR 0.53, for the release dated July 31, 2026. The 0.17-euro EPS gap equals 32.08 percent above that forecast, giving investors a concrete comparison for the next report.
Stock remains below yearly high
Siemens Healthineers was valued at EUR 43.5 billion on September 30, 2026. Its 52-week range was EUR 32.81 to EUR 49.71 as of September 29, 2026, placing the Lang & Schwarz price EUR 11.03 below the high and EUR 5.87 above the low.
The next scheduled earnings date shown by Investing.com is November 5, 2026. Until then, the combination of buyback execution, Accela expectations and the Q3 EPS comparison defines the key checkpoints for Siemens Healthineers stock.
EUR 38.68 at Lang & Schwarz
Siemens Healthineers was trading at EUR 38.68 at Lang & Schwarz on September 30, 2026, at 10:32 a.m. CEST, versus the EUR 38.61 prior close, plus 0.18 percent. Xetra is the primary exchange, where the stock trades under ticker SHLG.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHLG
- Primary exchange: Xetra
- Price Lang & Schwarz (as of September 30, 2026, 10:32 a.m. CEST): EUR 38.68
- Change versus prior close: plus 0.18 percent
- Prior close Lang & Schwarz (September 29, 2026): EUR 38.61
- Market capitalization: EUR 43.5 billion (as of September 30, 2026)
- 52-week range: EUR 32.81-49.71 (as of September 29, 2026)
- Sector / Industry: Healthcare / Medical Devices
